< Back to previous page
Researcher
Jan de Hoon
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today
Projects
1 - 8 of 8
- Targeting TRP channels to relief painFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- TRP - Tackling the Roots of PainFrom1 Oct 2021 → TodayFunding: Fund Recuperation Fiscal Exemption, BOF - projects
- Transient Receptor Potential (TRP) channels in Chemotherapy-Induced Peripheral Neuropathy (CIPN): Translational research from bench to bedsideFrom10 Sep 2018 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Antenatal Sildenafil To Prevent Pulmonary hypertension in congenital diaphragmatic Hernia (SToP-PH): moving from bench to clinical practiceFrom1 Oct 2017 → 30 Sep 2019Funding: IOF - Industrial Research Fund
- TRPLe - TRP channel Research Platform LeuvenFrom1 Oct 2017 → 30 Sep 2021Funding: Fund Recuperation Fiscal Exemption
- Target engagement biomarkers to bridge the translational gap haunting TRP channelsFrom1 Oct 2017 → 12 Jun 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Labeling of Enalapril from Neonates up to AdolescentsFrom1 Nov 2013 → 31 Oct 2018Funding: General Activities (Annex IV)
- Target engagement biomarkers for pain receptorsFrom1 Sep 2013 → 15 Nov 2017Funding: BOF - Doctoral projects
Publications
1 - 10 of 181
- Vascular read-out for TRP channel functionality on distal peripheral nerve endings in healthy men(2024)
Authors: Heleen Marynissen, Dorien Bamps, Jan de Hoon
- Functional Analysis of TRPA1, TRPM3, and TRPV1 Channels in Human Dermal Arteries and Their Role in Vascular Modulation(2024)
Authors: Heleen Marynissen, Dorien Bamps, Jan de Hoon
- Does etodolac affect TRPA1 functionality in vivo in human?(2023)
Authors: Heleen Marynissen, Dorien Bamps, Jan de Hoon
Pages: 531 - 537 - PHARMACOKINETICS OF ORAL REBAUDIOSIDE A IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ITS EFFECTS ON GLUCOSE HOMEOSTASIS: A PLACEBO-CONTROLLED CROSSOVER TRIAL(2022)
Authors: Caroline Simoens, Caroline Wuyts, Joris Van Loco, Jaak Billen, Jan de Hoon, Roman Vangoitsenhoven, Ann Mertens, Rudi Vennekens, Bart Van Der Schueren
Pages: 1 - 13 - Doppler ultrasound to assess the pharmacodynamic effects of splanchnic vasoactive compounds(2022)
Authors: Heleen Marynissen, Didier Bielen, Jan de Hoon
Pages: 1785 - 1794 - Relationship of the Calcitonin Gene-Related Peptide Monoclonal Antibody Galcanezumab Pharmacokinetics and Capsaicin-Induced Dermal Blood Flow in Healthy Subjects(2021)
Authors: Jan de Hoon
Pages: 440 - 452 - Interim results of a phase 1-2a trial of Ad26. COV2.S COVID-19 vaccine(2021)
Authors: Jan de Hoon
- Pharmacokinetics During Therapeutic Hypothermia for Neonatal Hypoxic Ischaemic Encephalopathy: A Literature Review(2020)
Authors: Karel Allegaert, Jan de Hoon, Heleen Marynissen
- Safety and immunogenicity of fully liquid and lyophilized formulations of an investigational trivalent group B streptococcus vaccine in healthy non-pregnant women: Results from a randomized comparative phase II trial(2020)
Authors: Jan de Hoon, Corinne Vandermeulen
Pages: 3227 - 3234 - Fit-for-Purpose Quality Control System in Continuous Bioanalysis during Long-Term Pediatric Studies (vol 21, 104, 2019)(2020)
Authors: Mohsin Ali, Jutta Tins, Bjoern B Burckhardt, Stephanie Laeer, Joerg Breitkreutz, Ingrid Klingmann, Florian Lagler, Jan de Hoon, Michiel Dalinghaus, Milica Bajcetic, et al.